妊娠期IBD硫嘌呤代谢变化及新生儿暴露结局
本研究纳入妊娠期或备孕的IBD女性,纵向监测母体硫嘌呤代谢物,并检测新生儿代谢物水平及结局。发现孕中期6-TGN下降、6-MMP升高,新生儿出生时低水平暴露,6周内清除,无贫血,但80%出现血小板增多和肝功能异常。
要点
- 孕中期6-TGN水平下降,6-MMP水平升高。
- 新生儿6周内清除硫嘌呤代谢物,无贫血。
- 80%新生儿自6周起出现血小板增多和肝功能异常,逐渐改善。
核心结论
- 妊娠中期6-TGN水平下降而6-MMP水平升高,新生儿低水平暴露硫嘌呤代谢物并于6周内清除,无贫血,但血小板增多和肝功能异常原因不明。
主要发现
- 孕中期母体6-TGN中位数179.0 pmol/8×10^8 RBCs,低于产后323.5(P<0.001)。
- 孕中期母体6-MMP中位数1103.0 pmol/8×10^8 RBCs,高于产后329.5(P<0.01)。
- 分娩时婴儿6-TGN中位数78.5 pmol/8×10^8 RBCs,低于母体217(P<0.001)。
- 所有婴儿6周时未检测到代谢物,无贫血,但80%出现血小板增多和肝功能异常并逐渐改善。
临床怎么用
- 妊娠期IBD患者使用硫嘌呤时,孕中期应关注6-TGN下降和6-MMP升高,必要时监测代谢物水平。
- 新生儿出生后需监测血常规和肝功能,尤其注意血小板增多和肝功能异常,尽管代谢物已清除。
局限性
- 新生儿血小板增多和肝功能异常的原因未明确。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Azathioprine and mercaptopurine are considered safe during pregnancy. However, the pharmacokinetic effects of pregnancy on thiopurine metabolism are undefined. AIMS: To characterise thiopurine metabolism in pregnancy and measure infant metabolite levels and outcomes. METHODS: Women with IBD who were taking a thiopurine and pregnant or trying to conceive were recruited. Maternal thiopurine metabolites were measured pre-conception, in each trimester, at delivery and post-partum. Infant metabolite levels, full blood examination and liver function testing were performed at birth, and repeated until levels undetectable and haematological and biochemical abnormalities resolved. RESULTS: Forty patients were included with measurements on at least two occasions, and two with only mother-baby levels at delivery. The median maternal 6-TGN level dropped in the second trimester compared with post-partum (179.0 vs 323.5 pmol/8 × 108 RBCs, P < 0.001) and the median 6-MMP level increased in the second trimester compared with post-partum (1103.0 vs 329.5 pmol/8 × 108 RBCs, P < 0.01). At delivery, the median 6-TGN level was lower in infants (n = 20) than mothers (78.5 vs 217 pmol/8 × 108 RBCs) (P < 0.001). Metabolites were not detected at 6 weeks in any infants. Anaemia was not seen, but thrombocytosis and abnormal liver biochemistry were detected in 80% of infants from 6 weeks, which gradually improved. CONCLUSIONS: 6-TGN levels decrease and 6-MMP levels increase in the second trimester of pregnancy. Infants are exposed to thiopurine metabolites at low levels with clearance by 6 weeks and no anaemia. The cause of infant thrombocytosis and abnormal liver biochemistry in the absence of metabolites is unclear.
引用
- Flanagan E, Wright EK, Hardikar W, et al. Maternal thiopurine metabolism during pregnancy in inflammatory bowel disease and clearance of thiopurine metabolites and outcomes in exposed neonates. Aliment Pharmacol Ther. 2021. PMID: 33608894. doi:10.1111/apt.16294
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。